Oriol Arpí

1.2k total citations
24 papers, 710 citations indexed

About

Oriol Arpí is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Oriol Arpí has authored 24 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Oriol Arpí's work include Lung Cancer Research Studies (7 papers), Peptidase Inhibition and Analysis (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Oriol Arpí is often cited by papers focused on Lung Cancer Research Studies (7 papers), Peptidase Inhibition and Analysis (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Oriol Arpí collaborates with scholars based in Spain, United States and United Kingdom. Oriol Arpí's co-authors include Ana Rovira, Joan Albanell, Federico Rojo, Sílvia Menéndez, Sandra Zazo, Edurne Arriola, Álvaro Taus, Aňa Lluch, Pîlar Eroles and Israel Cañadas and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Oriol Arpí

24 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oriol Arpí Spain	15	376	359	149	126	86	24	710
Mónica Musteanu Spain	14	552 1.5×	415 1.2×	181 1.2×	149 1.2×	121 1.4×	32	972
Masayuki Otsuka Japan	15	300 0.8×	343 1.0×	114 0.8×	121 1.0×	109 1.3×	73	847
Hideaki Mitsui Japan	18	320 0.9×	393 1.1×	206 1.4×	290 2.3×	69 0.8×	47	863
Dan Lu China	9	203 0.5×	458 1.3×	131 0.9×	85 0.7×	76 0.9×	16	694
Zizhen Feng China	12	272 0.7×	671 1.9×	145 1.0×	140 1.1×	48 0.6×	23	1.0k
Haizhen Lu China	13	231 0.6×	264 0.7×	128 0.9×	145 1.2×	45 0.5×	47	687
Fernando Pardal Portugal	16	236 0.6×	404 1.1×	211 1.4×	123 1.0×	85 1.0×	26	829
David Molkentine United States	16	357 0.9×	371 1.0×	125 0.8×	186 1.5×	84 1.0×	30	708
Lars Tharun Germany	15	434 1.2×	471 1.3×	179 1.2×	240 1.9×	118 1.4×	41	966
Shanhong Tang China	14	509 1.4×	516 1.4×	177 1.2×	72 0.6×	76 0.9×	30	1.1k

Countries citing papers authored by Oriol Arpí

Since Specialization

Citations

This map shows the geographic impact of Oriol Arpí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol Arpí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol Arpí more than expected).

Fields of papers citing papers by Oriol Arpí

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oriol Arpí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol Arpí. The network helps show where Oriol Arpí may publish in the future.

Co-authorship network of co-authors of Oriol Arpí

This figure shows the co-authorship network connecting the top 25 collaborators of Oriol Arpí. A scholar is included among the top collaborators of Oriol Arpí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oriol Arpí. Oriol Arpí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perera‐Bel, Júlia, Alejo Rodríguez‐Vida, Oriol Arpí, et al.. (2023). The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer. Scientific Reports. 13(1). 15287–15287. 6 indexed citations

Zazo, Sandra, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, et al.. (2020). Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer. Molecular Cancer Therapeutics. 19(8). 1696–1707. 24 indexed citations

Gónzález-Alonso, Paula, Sandra Zazo, Ester Martı́n-Aparicio, et al.. (2020). The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer. Cancers. 12(5). 1108–1108. 21 indexed citations

Rodríguez‐Vida, Alejo, Núria Juanpere, Oriol Arpí, et al.. (2019). Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models. Molecular Cancer Research. 17(9). 1931–1944. 27 indexed citations

Sánchez-Martín, Francisco Javier, Oriol Arpí, Laura Visa, et al.. (2019). HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer. Molecular Cancer Therapeutics. 18(11). 2135–2145. 42 indexed citations

Pineda, Estela, Anna Esteve‐Codina, Maria Martinez‐García, et al.. (2019). Glioblastoma gene expression subtypes and correlation with clinical, molecular and immunohistochemical characteristics in a homogenously treated cohort: GLIOCAT project.. Journal of Clinical Oncology. 37(15_suppl). 2029–2029. 4 indexed citations

Rocha, Pedro, Oriol Arpí, Álvaro Taus, et al.. (2017). P1.15-001 Ipilimumab Increases Th1/Th2 and Inflammatory Cytokines Counteracting Chemotherapy Effects in Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(11). S2043–S2043. 1 indexed citations

Esteve‐Codina, Anna, Oriol Arpí, Maria Martinez‐García, et al.. (2017). A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples. PLoS ONE. 12(1). e0170632–e0170632. 92 indexed citations

Arpí, Oriol, Álvaro Taus, Pedro Rocha, et al.. (2017). Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab. OncoImmunology. 7(2). e1395125–e1395125. 27 indexed citations

10.

Estival, Anna, Estela Pineda, Maria Martinez‐García, et al.. (2016). MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study. Annals of Oncology. 27. vi107–vi107. 1 indexed citations

11.

Zazo, Sandra, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, et al.. (2016). Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.. PubMed. 6(11). 2661–2678. 37 indexed citations

12.

Gelabert‐Baldrich, Mariona, Francisco Javier Sánchez-Martín, Alba Dalmases, et al.. (2016). Identification of molecular mechanisms of acquired resistance to trastuzumab in gastric cancer. European Journal of Cancer. 61. S124–S125. 1 indexed citations

13.

Cañadas, Israel, Álvaro Taus, Oriol Arpí, et al.. (2015). Angiopoietin-2 is a negative prognostic marker in small cell lung cancer. Lung Cancer. 90(2). 302–306. 18 indexed citations

14.

Martínez, Alejandro, Oriol Arpí, Sílvia Menéndez, et al.. (2015). Targeting the PI3K/AKT/mTOR pathway with MLN0128 (mTORC1/2 inh) and MLN1117 (PI3K alpha inh) in bladder cancer: Rational for its testing in clinical trials.. Journal of Clinical Oncology. 33(7_suppl). 369–369. 1 indexed citations

15.

Rincón, Raúl, Ion Cristóbal, Sandra Zazo, et al.. (2015). PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. Oncotarget. 6(6). 4299–4314. 82 indexed citations

16.

García-Parra, Jetzabel, Alba Dalmases, Beatriz Morancho, et al.. (2014). Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. European Journal of Cancer. 50(15). 2725–2734. 22 indexed citations

17.

Cañadas, Israel, Álvaro Taus, Iria González, et al.. (2014). High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients. Oncotarget. 5(14). 5246–5256. 34 indexed citations

18.

Cañadas, Israel, Federico Rojo, Álvaro Taus, et al.. (2013). Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer. Clinical Cancer Research. 20(4). 938–950. 107 indexed citations

19.

Rojo, Federico, Laia Domingo, María Sala, et al.. (2013). Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway. Cancer Epidemiology Biomarkers & Prevention. 23(2). 288–299. 10 indexed citations

20.

Arriola, Edurne, Israel Cañadas, Montserrat Arumí-Uría, et al.. (2011). MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. British Journal of Cancer. 105(6). 814–823. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact